It has also been suggested that BMSC-derived exosomal miR-9-3p repressed bladder cancer progression through Endothelial cell-specific molecule 1 (ESM1) downregulation, presenting a novel therapeutic target for bladder cancer therapy37. This evidence concerns the gene ESM1 and urinary bladder cancer.